Novel protein kinase cAMP-Activated Catalytic Subunit Alpha (PRKACA) inhibitor shows anti-tumor activity in a fibrolamellar hepatocellular carcinoma model.
暂无分享，去创建一个
O. Ubukata | S. Iwasaki | Akiko Toyota | K. Yoshida | M. Suzuki | T. Matsufuji | T. Komatsu | M. Goto | M. Miyamoto | Yoko Nagashima | Takayuki Momose | Tomoharu Tsukada | Ami Ohno | Yasuyuki Kaneta | Masafumi Suzuki